This announcement is a separate document:
Milestone Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Wills Robert James
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.